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 1 
Abstract 
 
Background: Much attention has been placed on the prenatal exposure as a risk for 
increasing prevalence of allergic disease in infants. The prenatal exposure to harmful 
chemicals in foetal stage is likely to affect the developing immune system, and thus that 
newborns might acquire predisposition to allergic disease such as atopic dermatitis 
(AD). 
 
Objective: To investigate comprehensively the impact of foetal exposure to a number of 
persistent organic pollutants (POPs) as a prenatal risk for the AD development. 
 
Methods: In our birth cohort study set up in Japan, Chiba, total 81 infants’ umbilical 
cord tissues were measured to the exposure levels of 15 polychlorinated biphenyl 
(PCBs) congeners, dichlorodiphenyltrichloroethane (p,p’-DDT), 
dichlorodiphenyldichloroethylene (p,p’-DDE), β-hexachlorocyclohexane (β-HCH), 
hexachlorobenzene (HCB), cis-nonachlor, trans-nonachlor, mirex, oxychlordane, and 
27 polybrominated diphenyl ether (PBDEs) congeners. Following up the infants, the 
associations between the exposures and the onset of the AD were examined. 
Results: The detection rate of p,p’-DDE was the highest, followed by β-HCH, the total 
levels of PCBs, HCB, and the total levels of PBDEs, respectively. These chemical 
compounds accounted for approximately 90% of the mass of all chemical compounds 
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detected, and among them the total levels of PBDEs were associated with the 
development of AD at seven months of age, with the risk of AD development decreased 
in relation to the increased levels of total PBDEs. 
Conclusion: The infants were exposed to various POPs before birth and the composite 
contamination was found. It is suggested that PBDE exposure is a possible disturbing 
factor for developing immune system in infants. 
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Introduction 
 
It has been known that a wide range of harmful chemical compounds was detected in 
the human body, which poses a serious threat to human health. Among the chemical 
compounds, persistent organic pollutants (POPs) such as polychlorinated biphenyls 
(PCBs) and polybrominated diphenyls (PBDEs) have received considerable attention 
from researchers because they have a bioaccumulation potential in long-term and exert 
various toxicities. The toxic actions extend to disruption in endocrine, reproductive, 
nervous and even immune systems, resulting in detrimental consequences to their 
normal functions. So far, there has been much evidence that exposure to PCBs is 
associated with decreased thyroid hormone levels, altered reproductive hormone levels, 
impaired spermatogenesis, ovarian dysfunction, and neurodevelopmental disturbance 
(Grandjean and Landrigan, 2006; Meeker and Hauser, 2010; Sharpe, 2010; Craig et al., 
2011; Boas et al., 2012). PCB exposure also could lead to alterations in lymphocyte 
subsets, modulating immune responses (Kunisue et al., 2006; Glynn et al., 2008; 
Horvathova et al., 2011; Andra and Makris, 2012). Likewise, accumulated PBDEs, 
which had been used as flame-retardants for many household products including 
electronic equipment, textiles, and furnishings, could exert the similar 
health-threatening behaviour to PCBs (Clarke and Smith, 2011; Dingemans et al., 2011; 
Andra and Makris, 2012) and seem to have immune-modulating effects (Lundgren et al., 
2009; Hong et al., 2010). 
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Developmental immunotoxicity induced by the accumulated chemical compounds is a 
growing health concern since it could lead to the aberrant balanced immune responses, 
resulting in immune disease such as autoimmune and allergic disease (Chen et al., 2006). 
It can be assumed that the chemical induced-dysregulation of T helper (Th) cell 
responses is an underlying mechanism by which susceptibility to allergic disease is 
enhanced. In fact, an increasing number of studies suggests that exposure to POPs can 
be a risk factor for the development of allergic diseases, and even related to their onset 
(Luster et al., 2003). There are continuing reports for PCB exposure in human despite 
the exposure levels decreasing worldwide, and it is jeopardizing children’s health 
because PCBs cross the placenta into the foetuses (Park et al., 2008). Grandjean et al. 
(2010) reported that PCB exposure was likely to contribute to the development of 
asthma in children. There is, on the other hand, evidence showing no relationship 
between the exposure to harmful chemicals and the development of allergic diseases 
(Noakes et al., 2006), the causal relationship being controversial. Exposure to PBDEs 
can also be considered a contributing factor to allergic diseases because of their 
structural similarity to PCBs, but so far there has been no epidemiological evidence for 
such health-threatening effects of PBDEs. Given their bioaccumulation potential and 
chemical similarity, it is likely that other similar agricultural pesticides are potential 
immune-toxicants and thus to have influence on the development of allergic disease. 
However, no epidemiological study has reported the associations of exposure to the 
other POPs with the development of allergy. 
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As with many developed countries, an increasing number of infants who present with 
allergic diseases have been reported in Japan. Among several allergic diseases, the 
development of atopic dermatitis (AD) in infants is of particular interest because it is 
often evident within only a few months after birth. Infants with AD are likely to develop 
severe allergic diseases such as food allergy and asthma, during the so-called allergy 
March (Spergel and Paller, 2003). These facts implicate that AD is a logical target as 
the earliest presentation of immune dysregulation caused by prenatal exposure to the 
chemical compounds, highlighting the need to assess its impact. To identify chemical 
compounds that have the potential risk for AD, we set up a prospective birth cohort 
study examining the relationship between prenatal exposures to the various chemicals 
and the development of AD at the age of 7 months. In this study, we measured the 
concentrations of the chemicals in the umbilical cord tissues to evaluate the prenatal 
exposure. It is appropriate to use the umbilical cord tissues because they more directly 
reflect the accumulation of chemicals in foetuses than does cord blood serum 
(Kawashiro et al., 2008). 
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Method 
Cohort study 
Our prospective birth cohort study at Kawatetsu-Chiba Hospital in Japan recruited 254 
pairs of mother and child. After delivery, baseline characteristics of parents, including 
data on parental allergic disease, were obtained through a questionnaire. The mothers 
answered subsequent questionnaires at 1, 4 and 7 months with a main focus on their 
feeding method, the presence or absence of skin rash lasting more than 2 months and its 
distribution. Based on the questionnaire at 7 months, one of the authors interviewed 
mothers by telephone about eczema at 7 months in detail, determining the presence of 
atopic diagnosis. All participating mothers provided written informed consent to 
participate in the study, which was approved by the local ethics committee. 
Sample collection and measurement of chemical compounds 
Umbilical cord tissues were collected immediately after birth in the delivery room. The 
tissues were cut at a distance from 10 to 15 cm from the neonatal umbilicus. After 
maternal and neonatal blood were wiped off with clean gauze the tissues were stored in 
glass containers that had been washed with acetone and heat-treated at 400 °C to 
prevent contamination of other chemicals, then being kept at -80 °C for long-term 
storage. Eighty-six umbilical cords were selected that were long enough to enable 
measurement of various chemical compounds (approximately 10 g) and were subject to 
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high-resolution gas chromatography/high-resolution mass spectrometry 
(HRGC/HRMS). 
The chemical compounds that were measured are as follow: 15 PCB congeners (CB-28, 
48/47, 74, 99, 118, 138, 146, 153, 156, 163/164, 170, 180, 182/187, 194, and 199); 27 
PBDE congeners (BDE-3, 7, 15, 17, 28, 47, 49, 66, 71, 77, 85, 99, 100, 119, 126, 138, 
153, 154, 156, 183, 184, 191, 196, 197, 206, 207, and 209); 
dichlorodiphenyltrichloroethane (p,p’ -DDT), dichlorodiphenyldichloroethylene (p,p’ 
-DDE), β-hexachlorocyclohexane (β-HCH), hexachlorobenzene (HCB), cis-nonachlor, 
trans-nonachlor, mirex, and oxychlordane, The measurements of PBDEs were 
performed by SRL, Inc. (Tokyo, Japan) and those of PCBs ant the other POPs by 
Shimazu Techno-Research, Inc. (Kyoto, Japan) in accordance with the procedure as 
earlier described (Kawashiro et al., 2008). The limit of qualification (LOQ) for PCBs 
was 0.1 pg/g-wet weight and that for PBDEs and the other POPs were 0.2 pg/g-wet 
weight; the measurement values less than the LOQ were set to zero. 
Statistical analysis 
Concentrations of chemicals in the umbilical cord were used in the statistical analysis. 
Several variables were described employing frequencies and proportions for categorical 
data, and means and standard deviations (SD) for continuous variables. We compared 
patient characteristics using Fisher’s exact test for categorical outcomes and t-tests for 
continuous variables, as deemed appropriate. Since the data of various chemicals did 
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not have a normal distribution, nonparametric tests were used. To evaluate the 
correlation between chemical concentration and the occurrence of AD, multivariate 
analysis was performed using the logistic regression model with a stepwise selection 
procedure. The stepwise procedure was set to a threshold of 0.05 for inclusion and 0.05 
for exclusion. In addition, the Akaike Information Criterion (AIC), a measure of the 
relative quality of fitness in a statistical model, was applied to determine the best model 
among those tested. A P-value of less than 0.05 was employed to indicate statistical 
significance. All statistical analyses were performed with the use of R (ver. 3. 1. 0) 
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Results 
Cohort and basic statistics 
To measure the concentrations of POPs, sufficient amounts of umbilical cord tissues 
were required. Of all umbilical cords collected at delivery, 86 umbilical cords were 
longer than 25 cm, and these were used for further analyses. The concentrations of all 
chemicals are summarised in Table 1. With regards to the determination of the AD 
presence, only 81 participants were evaluated because of incomplete questionnaires. 
The number of infants who developed AD at 7 months of age was 27. Baseline 
characteristics of infants with AD and those without AD are listed in Table 2. There 
were no significant differences between the two groups. 
Chemical profile of umbilical cords 
15 PCB congeners, 27 PBDE congeners, and the other POPs including p,p’-DDT, 
p,p’-DDE, β-HCH, HCB, cis-nonachlor, trans-nonachlor, mirex, oxychlordane were 
investigated. The total concentrations of all PCB congeners (ΣPCB-15) and those of 27 
PBDE congeners (ΣPBDE-27) were set to be analysed. Table 1 represents the levels of 
the all POPs detected in the umbilical cord tissues, with indicating the percentage of 
total concentrations of the chemical compounds. All POPs were detected in most of the 
tissues, with the most commonly detected POPs being p,p’-DDE, β-HCH, PCBs, and 
PBDEs. p,p’-DDE was found at the highest concentrations, followed by β-HCH, Σ
PCB-15, ΣPBDE-27, and HCB, at 122.7 pg/g-wet, 73.33 pg/g-wet, 60.63 pg/g-wet, 
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55.06  pg/g-wet and 22.89 pg/g-wet, respectively. These accounted for about 90% of 
the mass of all chemical compounds detected in the umbilical cord tissues. The other 
POPs were found at relatively low levels. In addition, ΣPCB-15 levels were strongly 
correlated with those of other POPs but not with ΣPBDE-27 (Table 3). We conducted 
factor analysis for all the POPs variables measured in this study, in preparation for 
subsequent statistical tests for association analysis (Table 4). 
Correlation between POPs and development of AD 
Using results form factor analysis, we compared the levels of four chemical compounds, 
including ΣPCB-15, β-HCH, trans-nonachlor, and ΣPBDE-27, in umbilical cords 
between the 2 groups: the AD group (N = 27) and the non-AD group (N = 54). 
Interestingly, only ΣPBDE-27 levels were significantly different between the 2 groups, 
as determined by univariate analysis (Table 5). The concentrations of ΣPBDE-27 were 
lower in the AD group than the non-AD group (P = 0.006, Mann–Whitney test with 
Bonferroni correction). However, the total IgE levels in cord blood were not correlated 
with the levels of ΣPBDE-27, ΣPCB-15 and any other POPs (data not shown). In 
confirming the relationship between ΣPBDE-27 levels and AD, the logistic regression 
analysis revealed that the risk for developing AD was decreased in middle levels (odds 
ratio [OR], 0.263; confidence interval [CI], 0.084–0.821) and high levels of Σ
PBDE-27 (OR, 0.136; CI, 0.037–0.501) (Table 6). Besides ΣPBDE-27, no other 
associations were found between chemical exposure and the development of AD. 
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Discussion 
The results of this study showed that the prevalence of AD at 7 month of age might be 
negatively associated with the summation of the concentrations of 27 PBDE congeners 
in umbilical cord but not the sum of the PCB congeners and the other POPs, indicating 
the potential impact of the foetal exposure to PBDEs for early developing AD in infants. 
In the present study, AD was defined using a questionnaire as well as telephone 
interview, but blood examination was not performed. Therefore, it was inconclusive 
whether the AD developed by the age of 7 months was atopic or non-atopic. However, 
we consider that this study has important implications as the first study to show an 
association between foetal exposure to PBDEs and the development of AD in the first 
few months of life. 
Some studies have suggested that PCB has the potential to act as an immune-disruptor 
to induce the skewing of immune cell population which leads to allergic response 
(Reichrtova et al., 1999; Strenzke et al., 2001; Horvathova et al., 2011) By contrast, 
Grandjean and his colleagues have shown that children with AD had lower prenatal 
PCB exposures than did nonallergic children (Grandjean et al., 2010). We failed to 
observe any correlation between PCB exposure and the development of AD, despite 
detection of PCBs in all umbilical cords examined. It might be possible that postnatal 
exposure to PCB have some role in the later development of subsequent allergic 
diseases. In the present study, however, the clinical endpoint was set up earlier in order 
to evaluate the impact of intrauterine exposure, and thus we did not examine the effect 
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of breastfeeding, which is an influential postnatal environmental factor as well as 
intrauterine exposure. 
As with PCBs, p,p’-DDE (the metabolite of p,p’-DDT) and β-HCH were detected at 
relatively high levels in the umbilical cords. These POPs have been reported to exert 
adverse immunological effect, possibly skewing the T-cell population ratio into 
preponderance of T helper (Th) 2 cells, which are critical to the pathogenesis of allergic 
disease (Daniel et al., 2001, 2002). However, we were not able to identify any 
associations between p,p’-DDT, p,p’-DDE, β-HCH, and AD. Likewise, other POPs, 
including HCB, cis-nonachlor, and trans-nonachlor, did not influence the development 
of AD, although these were detected at low levels in umbilical cords and they were not 
expected to play a major health-threatening role. 
Unlike the aforementioned chemical compounds that we examined, our results showed 
that PBDEs might exert a suppressive action on the onset of AD in early infancy. Given 
that the concentrations of PBDEs in umbilical cord tissue were not associated with the 
total IgE levels, they might not be involved in Th1/Th2 unbalance and the aberrant 
production of IgE. PBDEs might counteract the development of AD through the 
interference with other certain immune cell functions, resulting in the suppression of 
AD. This notion could be supported by recent interesting findings. The activation of 
Aryl hydrocarbon receptor (AhR) has the important role in the differentiation of T 
regulatory 1 cell (Tr1 cell) that could suppress the aberrant inflammation caused by 
allergic reaction (Apetoh et al., 2010). Once AhR antagonists bind to the intracellular 
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receptor, the activated AhR compounds are translocated to the nucleus in which they 
upregulate the expression of interleukin (IL)-10 and IL-21 that are involved in the 
development of Tr1 cell (Apetoh et al., 2010). Interestingly, PBDEs are one of agonists 
of AhR and thus they have the ability to activate AhR (Peters et al., 2006). Given that 
the balance of Th cell development is skewed to Tr1 cells under the effect of PBDEs, it 
is hardly surprising that the exposure to PBDEs is correlated to the decreasing incidence 
of AD. 
There is an essential conundrum left behind this study as to why the difference occurred 
between the outcome of PBDEs exposure and that of PCBs in spite of their structural 
similarity and their binding ability to AhR. Unfortunately, it is difficult to draw a 
conclusion of this problem in our study, but arguably PBDEs could affect intracellular 
signal pathways differently from PCBs, although both PBDEs and PCBs signal 
transduction are mediated by the same receptor, AhR. In fact, the toxicity equivalence 
varies among them, and several studies have reported that the toxicity of PBDEs is 
substantially lower compared with that of PCBs (Chen and Bunce, 2003). Further study 
is required to clarify the difference in immune cell responses to PBDEs and PCBs. 
Moreover, there are various congeners and isomers of them that have a wide range of 
the toxicity, the different property, the binding affinity to AhR, and the ability of 
transactivation of downstream target genes. Taking these facts into consideration, it is 
possible that either specific congeners/isomers of PBDEs and PCBs, or the combination 
of them could be associated with unique outcomes during the immunological 
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development in infancy. It is of great interest for human health to elucidate how PBDEs 
interact with neonates’ immune system, and to examine the various properties of PBDE	 
congeners and isomers. 
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Conclusion 
It is unlikely that the high levels of any POPs detected in umbilical cord tissues 
contribute to the development of AD in infants, and that prenatal exposures to POPs are 
suspected as risk factors—at least in the population examined herein. In our study, 
foetal exposure to PBDEs was found to have a significant impact on suppression of AD 
in early infancy but not PCB and the other POPs exposure. Further studies in wider 
populations are necessary to produce more precise and generalised data, in order to 
understand the effects of the accumulated POPs on infant’s immune system. It seems 
that a variety of POPs, including PBDEs congeners, isomers and other organic 
compounds, exert differing immune-modulating effects. In addition, large amounts of 
data in a epidemiological research are required to validate the impact of foetal POPs 
exposure combined with other environmental factors such as maternal lifestyles, and to 
assess the current exposure condition of the mothers and infants, because it has been 
changing reflecting on the present-day environments in our society. 
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Tables 
 
Table 1. Concentration of POPs detected in umbilical cord tissue. p,p’-DDE; 
dichlorodiphenyldichloroethylene, β-HCH; β-hexachlorocyclohexane, ΣPCB-15; the 
summation of 15 PCB congeners, ΣPBDE-27; the summation of 27 PBDE congeners, 
hexachlorobenzene (HCB), p,p’-DDT; dichlorodiphenyltrichloroethane.  
 
N Concentration means
(pg/g-wet)
Percentage (%) Cumulative percentage
p,p '-DDE 81 122.7 33.4 33.4
β-HCH 81 73.33 20.0 53.4
ΣPCB-15 81 60.63 16.6 70.0
ΣPBDE-27 81 55.06 15.0 85.0
HCB 81 22.89 6.20 91.2
Trans-nonachlor 81 16.17 4.40 95.6
Oxychlordane 81 8.506 2.30 97.9
p,p '-DDT 81 4.203 1.10 99.1
Cis-nonachlor 81 2.243 0.60 99.7
Mirex 81 1.074 0.30 1.00
 21 
Table 2. Baseline characteristics of AD and control groups. 
Statistical analyses were performed with aFisher’s exact test, bMann–Whitney U-test, 
and ct-test. 
 
Characteristics AD (N  = 27) P-value
Baby’s sex [boys (%)] 18 (66.7%) 0.477a
Maternal age [years , mean ± SD] 32.7 ± 4.7 0.659b
Gestational age [months, mean ± SD] 39.3 ± 1.4 0.034b
Birth weight [g, mean ± SD] 3053.5 ± 388.8 0.324c
Maternal allergic history [number (%)] 12 (44.4%) 0.342a
Paternal allergic history [number (%)] 12 (44.4%) 0.640a
Maternal smoking [number (%)] 8 (29.6%) 0.409a
Older siblings [number (%)] 7 (25.9%) 0.328a
Pet ownership [number (%)] 9 (33.3%) 0.081a
11 (20.4%)
20 (37.0%)
8 (14.8%)
31 (57.4%)
31.6 ± 4.2
Non-AD (N = 54)
38.6 ± 1.4
3011.7 ± 404.2
17 (32.1%)
21 (38.9%)
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Table 3. Spearman’s rank correlation coefficients between concentrations of ΣPCB-15, 
ΣPBDE-27, and other POPs. 
* rs > 0.40. ** rs>0.70.  
 
 
p,p '-DDE β-HCH ΣPCB-15 ΣPBDE-27 HCB Trans-nonachlor Oxychlordane p,p '-DDT Cis-nonachlor Mirex
p,p '-DDE 1   
β-HCH 0.740** 1   
ΣPCB-15 0.754** 0.681*  1   
ΣPBDE-27 0.079    0.055    0.113   1   
HCB 0.731** 0.872** 0.789** 0.017   1   
Trans-nonachlor 0.663*  0.601*  0.804** -0.039   0.740** 1   
Oxychlordane 0.699*  0.679*  0.816** -0.069   0.812** 0.973** 1   
p,p '-DDT 0.739** 0.624*  0.665*  0.047   0.679*  0.629*  0.625*  1   
Cis-nonachlor 0.688*  0.648*  0.835** -0.024   0.784** 0.950** 0.916** 0.698*  1   
Mirex 0.362    0.389    0.769** 0.075   0.494*  0.559*  0.558*  0.417*  0.607*  1   
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Table 4. Factor analysis for POPs detected in the umbilical cord tissues. 
 
Communality Factor 1 Factor 2 Factor 3 Factor 4
Trans-nonachlor 1.00 0.99 0.39 0.45 -0.06
Oxychlordane 0.96 0.97 0.53 0.54 -0.03
Cis-nonachlor 0.94 0.96 0.54 0.60 -0.08
ΣPCB-15 0.92 0.52 0.94 0.67 -0.03
p,p '-DDE 0.83 0.43 0.85 0.63 0.42
Mirex 0.61 0.32 0.67 0.33 -0.32
p,p '-DDT 0.60 0.35 0.75 0.50 0.26
HCB 0.57 0.42 0.62 0.73 0.22
β-HCH 0.66 0.58 0.59 0.78 0.26
ΣPBDE-27 0.04 -0.06 0.02 0.04 0.18
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Table 5. Comparison of the levels of the representative POPs. Median and interquartile 
range (IQR) is shown here for each POPs both in AD and control groups. 
Statistical test were performed by means of Mann-Whitney U-test (*P < 0.05). 
 
 
 
Median (IQR) N Median (IQR) N           P-value
β-HCH 54.53 (41.85-100.1) 27 51.64 (33.76-90.95) 54 0.806  
ΣPCB-15 66.51 (38.10-98.24) 27 57.69 (38.30-66.58) 54 0.685  
ΣPBDE-27 41.00 (31.00-56.00) 27 54.50 (43.00-72.00) 54 0.006*
Trans-nonachlor 11.23 (8.216-20.91) 27 12.88 (8.000-20.30) 54 0.916  
AD group Non-AD group
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Table 6. Cases of AD according to ΣPBDE-27 tertile category. 
Logistic regression analysis was done according to the tertile category. Low group, Σ
PBDE-27 < 42 pg/g-wet weight; Middle gruop, 42 pg/g-wet weight ≤ ΣPBDE-27 < 63 
pg/g-wet weight; High group, 63 pg/g-wet weight ≤ ΣPBDE-27. OR; adjusted odds 
ratio, CI; confidence interval. * P<0.05. 
 
AD case [number(%)] OR 95% CI P-value
ΣPBDE-27 Low 16 (57.1%) 1 1
Middle 7 (25.9%) 0.263 0.084-0.821 0.022*
High 4 (15.4%) 0.136 0.037-0.501 0.003*
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